Laura Lee Sandler, Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 5,000 shares at $93.85 ($472K) on 2026-07-01, disclosed to the SEC on 2026-07-01.
Scheduled sale ($472k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.85 | 2,237 | $210K | 44.5% |
| 2 | $94.75 | 2,263 | $214K | 45.4% |
| 3 | $95.47 | 500 | $48K | 10.1% |
| Total | $94.42 avg | 5,000 | $472K | 100% |
| Filing → |
| ORKA | SELL | 2026-05-01 | $319K | — | Filing → |
| ORKA | SELL | 2026-03-17 | $25K | — | Filing → |
| ORKA | SELL | 2026-03-02 | $168K | — | Filing → |